Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

Merck, a major New Jersey-based pharma company currently developing a vaccine against HPV, has decided to expand its facilities here in the region, investing around $650 million and creating more ...

Merck recently disclosed plans to expand its hiring in Durham by 100 more employees in the next few years to hike output of a bladder cancer drug.

A former FDA safety officer inspected Merck’s Durham, North Carolina, plant and said hygiene concerns were downgraded. Merck is going to help make Johnson & Johnson COVID vaccine.

Merck’s 262-acre facility in north Durham will be one of two in the country to help ramp up manufacturing of Johnson & Johnson’s one-shot vaccine — part of a massive effort to help stop the ...

Also, Merck’s Durham office has 10 active Employee Business Resource Groups, which are voluntary efforts led by employees who “aim to foster a diverse, inclusive work environment through ...

A Merck spokesman did not respond at the time when asked whether local authorities had been involved. The second noose was reported to the Durham County Sheriff’s Office last week, according to ...

DURHAM The federal government will spend $105.4 million outfitting Merck’s Durham plant for the production of Johnson & Johnson’s COVID-19 vaccine, Merck confirmed Wednesday.

According to a federal database, Merck’s Durham facility has not been inspected since 2018. Before that it was inspected in 2016 and 2014. Its 2020 on-site inspection was put off due to the ...

A former FDA safety officer inspected Merck’s Durham, North Carolina, plant and said hygiene concerns were downgraded. Merck is going to help make Johnson & Johnson COVID vaccine.

A former FDA safety officer inspected Merck’s Durham, North Carolina, plant and said hygiene concerns were downgraded. Merck is going to help make Johnson & Johnson COVID vaccine.